Canopy Growth (TSE:WEED) Stock: Insider Terry Yanofsky Sells 14,920 Shares

Key Points

• Director Terry Yanofsky sold 14,920 Canopy Growth shares at an average price of C$1.29, generating C$19,246.80. His remaining stake fell 16.17% to 77,333 shares.
• Canopy Growth shares declined 3.8% to C$1.27, near the company’s 52-week low of C$1.18. The cannabis company reported C$81.17 million in quarterly revenue and a loss of C$0.03 per share.
• Analyst sentiment remains a “Moderate Buy”, though Alliance Global Partners lowered its price target to C$1.60 from C$1.80; the consensus target is C$1.88.

Canopy Growth Corp (TSE:WEED - Get Free Report) Director Terry Yanofsky sold 14,920 shares of Canopy Growth stock in a transaction dated Monday, September 28th. The shares were sold at an average price of C$1.29, for a total value of C$19,246.80. Following the completion of the sale, the director owned 77,333 shares of the company's stock, valued at C$99,759.57. This trade represents a 16.17% decrease in their position.

Canopy Growth Trading Down 3.8%

Shares of TSE WEED traded down C$0.05 on Wednesday, reaching C$1.27. 1,422,628 shares of the company traded hands, compared to its average volume of 1,569,084. Canopy Growth Corp has a fifty-two week low of C$1.18 and a fifty-two week high of C$3.28. The company has a 50 day moving average of C$1.34 and a 200 day moving average of C$1.40. The company has a current ratio of 3.04, a quick ratio of 2.32 and a debt-to-equity ratio of 40.27. The stock has a market capitalization of C$537.26 million, a PE ratio of -1.90, a P/E/G ratio of -0.01 and a beta of 1.63.

Canopy Growth (TSE:WEED - Get Free Report) last released its earnings results on Friday, August 7th. The company reported C($0.03) earnings per share (EPS) for the quarter. Canopy Growth had a negative return on equity of 29.85% and a negative net margin of 73.95%.The company had revenue of C$81.17 million during the quarter. On average, equities research analysts forecast that Canopy Growth Corp will post -0.69 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Alliance Global Partners cut their price target on shares of Canopy Growth from C$1.80 to C$1.60 in a research note on Tuesday, June 16th. Two research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of C$1.88.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.